Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemoglobin subunit beta Cysteine 93 (beta-Cys93) is a highly conserved and chemically reactive amino acid residue located on the surface of the hemoglobin molecule (UniProt P68871). It plays a critical role in the physiological regulation of blood pressure and oxygen delivery through its interaction with nitric oxide (NO), forming S-nitrosohemoglobin (SNO-Hb) (PubMed 12193634). This S-nitrosylation process is oxygen-dependent, allowing hemoglobin to act as a dynamic sensor and transporter of NO bioactivity throughout the vascular system (PubMed 21810405). In the context of disease, beta-Cys93 is a focal point for oxidative damage and has been investigated as a site for therapeutic intervention in conditions like sickle cell disease and hypoxia. By covalently modifying this residue, researchers aim to stabilize the high-affinity (R-state) conformation of hemoglobin, thereby preventing the polymerization of sickle hemoglobin or enhancing oxygen uptake in low-oxygen environments (PubMed 16107501). Furthermore, the reactivity of beta-Cys93 is a key consideration in the development of hemoglobin-based oxygen carriers (HBOCs) to mitigate the side effects of NO scavenging and vasoconstriction. Its unique position and reactivity make it a significant target for both physiological signaling and pharmacological modulation.
Facilitation of S-nitrosylation to regulate vasodilation; covalent modification of the thiol group to stabilize the R-state (relaxed) conformation of hemoglobin, thereby increasing oxygen affinity and preventing hemoglobin polymerization.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin subunit beta Cysteine 93 (beta-Cys93) (beta-Cys93).